Abbreviations: Xeloda: capecitabine; AC: anthracycline and cyclophosphamide; VEGF mAb: vascular endothelial growth factor monoclonal Antibody; TBD: to be determined.
R&D
R&D Pipeline
Building balanced and differentiated pipeline covering products from early- to late-stage through both in-house development and in-licensing.
.
Assets
Indication
Combo
Development area
Pre-clinical
IND
Phase I
Phase II
Phase III
NDA
Commercial
Rights
